News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DiscoveryBioMed Garners Funding from the National Institutes of Health (NIH) to Support a Metabolic Diseases Drug Discovery Program



7/2/2012 9:58:38 AM

BIRMINGHAM, Ala.--(BUSINESS WIRE)--DiscoveryBioMed, Inc. (DBM) announces today funding of its Phase I Small Business Innovation Research (SBIR) grant, totaling nearly $222,000, by the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institute of Health. The award will focus on high-throughput screening and discovery of new drugs that stimulate endogenous secretion of adiponectin, an established biomarker with multiple salutary effects on the prevention of obesity-related diseases, from human adipocytes.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES